ZEISS CLARUS 700 Receives NMPA Approval in China
"Integrating ultra-widefield imaging, unsurpassed clarity, and AI-enhanced capture, the CLARUS 700 redefines fundus angiography benchmarks. It will provide unparalleled diagnostic precision for Chinese doctors and unprecedented comfort for their patients," says Maxwell Liu, Head of Sales & Services at ZEISS Medical Technology China.
Ultra-widefield fluorescein angiography serves as a highly valuable examination tool for assessing nonperfused retinal areas. The ZEISS CLARUS 700 HD ultra-widefield fundus imaging camera is an advanced retinal imaging system that provides True Color, high-resolution images. It captures 133° 1 in a single image and up to 267° with multiple captures, offering detailed views of the retina. Equipped with both fluorescein angiography and live infrared imaging capabilities, the CLARUS 700 aids in diagnosing and monitoring retinal diseases 2. Furthermore, the fundus imaging camera offers innovative technology features including PrecisionFocus for quickly seeing details in the regions of interest, QuickCompare to compare pathology changes observed in past patient visits, and AutoBright so ophthalmologists can spend more time analyzing images and less time adjusting them.
More information about the CLARUS ® 700 from ZEISS can be found here.
1 CLARUS 700#white-paper
2 Xiao, Y., Dan, H., Du, X. et al. Assessment of early diabetic retinopathy severity using ultra-widefield Clarus versus conventional five-field and ultra-widefield Optos fundus imaging. Sci Rep 13, 17131 (2023). https://doi.org/10.1038/s41598-023-43947-5
Not all products, services or offers are approved or offered in every market and approved labeling and instructions may vary from one country to another. For country-specific product information, see the appropriate country website. Product specifications are subject to change in design and scope of delivery as a result of ongoing technical development. The statements of the healthcare professionals reflect only their personal opinions and experiences and do not necessarily reflect the opinion of any institution that they are affiliated with. The healthcare professionals alone are responsible for the content of their experience reported and any potential resulting infringements. Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the healthcare professionals' content. The healthcare professionals have a contractual or other financial relationship with Carl Zeiss Meditec AG and its affiliates and have received financial support.
Contact for investors
Sebastian Frericks
Director Investor Relations
Carl Zeiss Meditec AG
Phone: +49 3641 220 116
Mail: [email protected]
Contact for the press
Frank Smith
Head of Global Communications Ophthalmology
Carl Zeiss Meditec Inc.
Phone: +49 3641 220 331
Mail: [email protected]
www.zeiss.com/newsroom
Brief Profile
Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on the MDAX and TecDAX of the German stock exchange, is one of the world's leading medical technology companies. The Company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, to diagnose and treat eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 5,730 employees worldwide, the Group generated revenue of €2,066.1m in fiscal year 2023/24 (to 30 September).
The Group's head office is located in Jena, Germany, and it has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. The Center for Application and Research (CARIn) in Bangalore, India and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the Company's presence in these rapidly developing economies. Around 39 percent of Carl Zeiss Meditec AG's shares are in free float. Approx. 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.
For further information visit: www.zeiss.com/med
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Canada Standard
2 days ago
- Canada Standard
Hainan emerges as China's premier international medical tourism destination
HAIKOU, July 5 (Xinhua) -- Nestled in the coastal town of Boao in south China's Hainan Province, the Boao Lecheng International Medical Tourism Pilot Zone is rapidly becoming a leading hub for health and innovation in China, drawing increasing attention from around the world. Hailed as China's sole "medical special zone," the pilot zone is home to over 30 top-tier domestic and international medical institutions. Thanks to special policy support, the medical zone has introduced 485 advanced medicines and medical devices approved overseas but not yet available in the domestic market, benefiting over 130,000 patients. Plagued by growing lumps on his chest and back that interfered with his work, Canadian figure skating coach Mark Batka chose to undergo surgery during a four-day wellness trip to the pilot zone. "In Canada, it is more expensive, and also it takes time to book it. And I was here, so I thought I would give it a try and I was very happy and I think it went very well," he said. Mark is just one of many international visitors who have benefited from the medical zone's services, which go beyond world-class treatments to offer a holistic experience, ranging from premium health check-ups and a fusion of traditional Chinese and Western therapies to cultural activities like incense appreciation, tea ceremonies and calligraphy. The Boao Yiling Life Care Center, a premier integrated medical service provider within the medical zone, offers a wide range of services like health management, disease prevention, specialized treatments, rehabilitation, and mental wellness. Janet Wong, who is part of the Canadian wellness tour group with Mark, said she was astounded by the high-end health check-up she received at the life care center. "We were so amazed right from the start when we arrived," she said, adding that the treatments were excellent and the medical check-up was incredibly thorough. "In some ways, it does feel like a vacation," said Stephanie Wing See Yau, another member of the Canadian group, praising the center as a truly top-notch facility. "It's very impressive how they put all these treatments in one place," she said, noting that it's refreshing to see a focus on overall wellness, not just physical, but mental as well. She described the medical tour as a great experience and said she would definitely recommend it to her friends. As part of its push to become the "capital of medical tourism," the pilot zone has launched 25 specialized routes tailored to diverse needs, from traditional Chinese medicine and chronic disease management to luxury diagnostics and cosmetic rehabilitation, gaining growing popularity worldwide. It has also become a key platform supporting Hainan's efforts to build an international hub for tourism and consumption. In 2024, the pilot zone attracted over 410,000 medical visitors, up 36.76 percent year on year. So far this year, the medical zone has already welcomed 188,300 medical tourists from countries including Canada, Spain, Russia, Uzbekistan and Cuba. Kareldus Agas, director of International Tourism Promotion, Ministry of Tourism and Creative Economy of Indonesia, was deeply impressed by the comprehensive services in Lecheng after experiencing health projects featuring traditional Chinese cultural activities like calligraphy and Chinese cupping. He said Lecheng offered not only cutting-edge medical services but also a seamless blend of relaxation, wellness and spiritual healing, creating a truly remarkable experience. Even without the need for medical treatment, he expressed a strong desire to return, simply to enjoy the unique sense of relaxation it provides. The medical zone has established partnerships with over 180 pharmaceutical and medical device companies from 20 countries, ensuring access to advanced international medical services for both domestic and international visitors, said He Ying, an official with the medical tourism department of the Boao Lecheng International Medical Tourism Pilot Zone Administration. He added that the zone will continue to strengthen its service platforms and international reception capabilities, with the goal of becoming a world-class medical tourism destination. As part of its broader economic strategy, China is building Hainan into a Free Trade Port and aims to transform the province into a globally influential tourism and consumption destination by 2035.
Canada News.Net
2 days ago
- Canada News.Net
Hainan emerges as China's premier international medical tourism destination
HAIKOU, July 5 (Xinhua) -- Nestled in the coastal town of Boao in south China's Hainan Province, the Boao Lecheng International Medical Tourism Pilot Zone is rapidly becoming a leading hub for health and innovation in China, drawing increasing attention from around the world. Hailed as China's sole "medical special zone," the pilot zone is home to over 30 top-tier domestic and international medical institutions. Thanks to special policy support, the medical zone has introduced 485 advanced medicines and medical devices approved overseas but not yet available in the domestic market, benefiting over 130,000 patients. Plagued by growing lumps on his chest and back that interfered with his work, Canadian figure skating coach Mark Batka chose to undergo surgery during a four-day wellness trip to the pilot zone. "In Canada, it is more expensive, and also it takes time to book it. And I was here, so I thought I would give it a try and I was very happy and I think it went very well," he said. Mark is just one of many international visitors who have benefited from the medical zone's services, which go beyond world-class treatments to offer a holistic experience, ranging from premium health check-ups and a fusion of traditional Chinese and Western therapies to cultural activities like incense appreciation, tea ceremonies and calligraphy. The Boao Yiling Life Care Center, a premier integrated medical service provider within the medical zone, offers a wide range of services like health management, disease prevention, specialized treatments, rehabilitation, and mental wellness. Janet Wong, who is part of the Canadian wellness tour group with Mark, said she was astounded by the high-end health check-up she received at the life care center. "We were so amazed right from the start when we arrived," she said, adding that the treatments were excellent and the medical check-up was incredibly thorough. "In some ways, it does feel like a vacation," said Stephanie Wing See Yau, another member of the Canadian group, praising the center as a truly top-notch facility. "It's very impressive how they put all these treatments in one place," she said, noting that it's refreshing to see a focus on overall wellness, not just physical, but mental as well. She described the medical tour as a great experience and said she would definitely recommend it to her friends. As part of its push to become the "capital of medical tourism," the pilot zone has launched 25 specialized routes tailored to diverse needs, from traditional Chinese medicine and chronic disease management to luxury diagnostics and cosmetic rehabilitation, gaining growing popularity worldwide. It has also become a key platform supporting Hainan's efforts to build an international hub for tourism and consumption. In 2024, the pilot zone attracted over 410,000 medical visitors, up 36.76 percent year on year. So far this year, the medical zone has already welcomed 188,300 medical tourists from countries including Canada, Spain, Russia, Uzbekistan and Cuba. Kareldus Agas, director of International Tourism Promotion, Ministry of Tourism and Creative Economy of Indonesia, was deeply impressed by the comprehensive services in Lecheng after experiencing health projects featuring traditional Chinese cultural activities like calligraphy and Chinese cupping. He said Lecheng offered not only cutting-edge medical services but also a seamless blend of relaxation, wellness and spiritual healing, creating a truly remarkable experience. Even without the need for medical treatment, he expressed a strong desire to return, simply to enjoy the unique sense of relaxation it provides. The medical zone has established partnerships with over 180 pharmaceutical and medical device companies from 20 countries, ensuring access to advanced international medical services for both domestic and international visitors, said He Ying, an official with the medical tourism department of the Boao Lecheng International Medical Tourism Pilot Zone Administration. He added that the zone will continue to strengthen its service platforms and international reception capabilities, with the goal of becoming a world-class medical tourism destination. As part of its broader economic strategy, China is building Hainan into a Free Trade Port and aims to transform the province into a globally influential tourism and consumption destination by 2035.
Vancouver Sun
4 days ago
- Vancouver Sun
Japan plans 'world first' deep-sea extraction of critical minerals
TOKYO — Japan will starting January attempt to extract rare earth minerals from the ocean floor in the deepest trial of its kind, the director of a government innovation programme said Thursday. Earlier this week the country pledged to work with the United States, India and Australia to ensure a stable supply of critical minerals, as concern grows over China's dominance in resources vital to new technologies. Rare earths — 17 metals difficult to extract from the Earth's crust — are used in everything from electric vehicles to hard drives, wind turbines and missiles. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. China accounts for almost two-thirds of rare earth mining production and 92 per cent of global refined output, according to the International Energy Agency. A Japanese deep-sea scientific drilling boat called the Chikyu will from January conduct a 'test cruise' to retrieve ocean floor sediments that contain rare earth elements, said Shoichi Ishii, director of Japan's Cross-ministerial Strategic Innovation Promotion Programme. 'The test to retrieve the sediments from 5,500 metres (3.4 miles) water depth is the first in the world,' he told AFP. 'Our goal… of this cruise is to test the function of all mining equipment,' so the amount of sediment extracted 'doesn't matter at all', Ishii added. The Chikyu will drill in Japanese economic waters around the remote island of Minami Torishima in the Pacific — the easternmost point of Japan, also used as a military base. Japan's Nikkei business daily reported that the mission aims to extract 35 tonnes of mud from the sea floor over around three weeks. Each tonne is expected to contain around two kilograms (4.4 pounds) of rare earth minerals, which are often used to make magnets that are essential in modern electronics. Deep-sea mining has become a geopolitical flashpoint, with anxiety growing over a push by U.S. President Donald Trump to fast-track the practice in international waters. Beijing has since April required licences to export rare earths from China, a move seen as retaliation for U.S. curbs on the import of Chinese goods. Environmental campaigners warn that deep-sea mining threatens marine ecosystems and will disrupt the sea floor. The International Seabed Authority, which has jurisdiction over the ocean floor outside national waters, is meeting later this month to discuss a global code to regulate mining in the ocean depths. Our website is the place for the latest breaking news, exclusive scoops, longreads and provocative commentary. Please bookmark and sign up for our daily newsletter, Posted, here .
